Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Pala

Showing results (21-30 of 125) with videos related to

Pageof 13
Sort By:
Future Oncology (London, England)|September 12, 2017
Molecular and clinical features of second-generation anaplastic lymphoma kinase inhibitors: ceritinibTommaso De Pas, Laura Pala, Chiara Catania, et al.
Current Medicinal Chemistry|January 26, 2019
Obesity Therapy: How and Why?Sara Paccosi, Barbara Cresci, Laura Pala, et al.
Expert Opinion on Investigational Drugs|August 12, 2022
Investigational drugs for the treatment of thymic cancer: a focus on phase 1 and 2 clinical trialsFabio Conforti, Laura Pala, Tommaso De Pas, et al.
Acta Diabetologica|March 4, 2010
The diabetic cardiomyopathyRoberto Tarquini, Chiara Lazzeri, Laura Pala, et al.
Diabetes Research and Clinical Practice|August 16, 2016
Lower and higher-potency statins on glycemic control in type 2 diabetes: A retrospective cohort studyGianluca Bardini, Stefano Giannini, Carlo Maria Rotella, et al.
International Journal of Cardiology|May 15, 2017
Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events: A comprehensive meta-analysis of randomized controlled trialsMatteo Monami, Stefania Zannoni, Laura Pala, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 14, 2022
Online group lifestyle modification programs for obesity during the COVID-19 pandemic: The EDucation ONline (EDON) retrospective studyFederica Santagiuliana, Claudia Cosentino, Laura Pala, et al.
Acta Diabetologica|May 17, 2021
Glucose variability and periodontal disease in type 1 diabetes: a cross-sectional study-The "PAROdontopatia e DIAbete" (PARODIA) projectIlaria Dicembrini, Luigi Barbato, Lapo Serni, et al.
Diabetes, Obesity & Metabolism|March 14, 2020
Combined continuous glucose monitoring and subcutaneous insulin infusion versus self-monitoring of blood glucose with optimized multiple injections in people with type 1 diabetes: A randomized crossover trialIlaria Dicembrini, Laura Pala, Mariasmeralda Caliri, et al.
Acta Oncologica (Stockholm, Sweden)|March 13, 2018
Fatherhood during dabrafenib and trametinib therapy for metastatic melanomaEmilia Cocorocchio, Laura Pala, Angelo Battaglia, et al.
Pageof 13

Showing results (21-30 of 125) with videos related to

Sort By:
Pageof 13
Future Oncology (London, England)|September 12, 2017
Molecular and clinical features of second-generation anaplastic lymphoma kinase inhibitors: ceritinibTommaso De Pas, Laura Pala, Chiara Catania, et al.
Current Medicinal Chemistry|January 26, 2019
Obesity Therapy: How and Why?Sara Paccosi, Barbara Cresci, Laura Pala, et al.
Expert Opinion on Investigational Drugs|August 12, 2022
Investigational drugs for the treatment of thymic cancer: a focus on phase 1 and 2 clinical trialsFabio Conforti, Laura Pala, Tommaso De Pas, et al.
Acta Diabetologica|March 4, 2010
The diabetic cardiomyopathyRoberto Tarquini, Chiara Lazzeri, Laura Pala, et al.
Diabetes Research and Clinical Practice|August 16, 2016
Lower and higher-potency statins on glycemic control in type 2 diabetes: A retrospective cohort studyGianluca Bardini, Stefano Giannini, Carlo Maria Rotella, et al.
International Journal of Cardiology|May 15, 2017
Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events: A comprehensive meta-analysis of randomized controlled trialsMatteo Monami, Stefania Zannoni, Laura Pala, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 14, 2022
Online group lifestyle modification programs for obesity during the COVID-19 pandemic: The EDucation ONline (EDON) retrospective studyFederica Santagiuliana, Claudia Cosentino, Laura Pala, et al.
Acta Diabetologica|May 17, 2021
Glucose variability and periodontal disease in type 1 diabetes: a cross-sectional study-The "PAROdontopatia e DIAbete" (PARODIA) projectIlaria Dicembrini, Luigi Barbato, Lapo Serni, et al.
Diabetes, Obesity & Metabolism|March 14, 2020
Combined continuous glucose monitoring and subcutaneous insulin infusion versus self-monitoring of blood glucose with optimized multiple injections in people with type 1 diabetes: A randomized crossover trialIlaria Dicembrini, Laura Pala, Mariasmeralda Caliri, et al.
Acta Oncologica (Stockholm, Sweden)|March 13, 2018
Fatherhood during dabrafenib and trametinib therapy for metastatic melanomaEmilia Cocorocchio, Laura Pala, Angelo Battaglia, et al.
Pageof 13